# Intravenous Immunoglobulin After Relapse in Vasculitis

> **NCT00307658** · PHASE3 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 40 (—)

## Conditions studied

- ANCA + Vasculitides Relapsing Either Under Corticosteroid
- and Immunosuppressant Therapies or After One Year
- Post Treatment.

## Interventions

- **DRUG:** Intravenous immunoglobulins (human immunoglobulins G)

## Key facts

- **NCT ID:** NCT00307658
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-03
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 40 (—)
- **Last updated:** 2006-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00307658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00307658, "Intravenous Immunoglobulin After Relapse in Vasculitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00307658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*